Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo ; day:27 ; month:07 ; year:2022 ; extent:18
Advanced science ; (27.07.2022) (gesamt 18)

Creator
Kayabolen, Alisan
Akcan, Ugur
Özturan, Doğancan
Ulbegi‐Polat, Hivda
Sahin, Gizem Nur
Pinarbasi‐Degirmenci, Nareg
Bayraktar, Canan
Soyler, Gizem
Sarayloo, Ehsan
Nurtop, Elif
Ozer, Berna
Guney‐Esken, Gulen
Barlas, Tayfun
Yildirim, Ismail Selim
Dogan, Ozlem
Karahuseyinoglu, Sercin
Lack, Nathan A.
Kaya, Mehmet
Albayrak, Cem
Can, Fusun
Solaroglu, Ihsan
Bagci‐Onder, Tugba

DOI
10.1002/advs.202201294
URN
urn:nbn:de:101:1-2022072815091114743051
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kayabolen, Alisan
  • Akcan, Ugur
  • Özturan, Doğancan
  • Ulbegi‐Polat, Hivda
  • Sahin, Gizem Nur
  • Pinarbasi‐Degirmenci, Nareg
  • Bayraktar, Canan
  • Soyler, Gizem
  • Sarayloo, Ehsan
  • Nurtop, Elif
  • Ozer, Berna
  • Guney‐Esken, Gulen
  • Barlas, Tayfun
  • Yildirim, Ismail Selim
  • Dogan, Ozlem
  • Karahuseyinoglu, Sercin
  • Lack, Nathan A.
  • Kaya, Mehmet
  • Albayrak, Cem
  • Can, Fusun
  • Solaroglu, Ihsan
  • Bagci‐Onder, Tugba

Other Objects (12)

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19

Elevated soluble ACE2 activity in children and adults after SARS‐CoV‐2 exposure irrespective of laboratory‐confirmed infection

Elevated soluble ACE2 activity in children and adults after SARS‐CoV‐2 exposure irrespective of laboratory‐confirmed infection

ACE2: the molecular doorway to SARS-CoV-2

ACE2: the molecular doorway to SARS-CoV-2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19

Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19

Age and sex differences in soluble ACE2 may give insights for COVID-19

Age and sex differences in soluble ACE2 may give insights for COVID-19

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues

ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues

Related objects